Xylazine Testing Launched at Philadelphia Lab
Parkway Clinical Laboratories Inc. (PCL), has launched Xylazine testing via LCMSMS confirmation testing on urine specimens.
Read MorePosted by Chris Wolski | May 11, 2023 | Urinalysis & Toxicology |
Parkway Clinical Laboratories Inc. (PCL), has launched Xylazine testing via LCMSMS confirmation testing on urine specimens.
Read MorePosted by Melanie Hamilton-Basich | May 10, 2023 | Diagnostic Technologies |
A team developed a simple nomogram based on easily accessible and automatable detected routine clinical indicators to reduce missed diagnosis and misdiagnosis of Wilson’s disease.
Read MorePosted by Chris Wolski | May 9, 2023 | Company News |
Revvity, Inc. officially launches today as a science-based solutions company that leverages innovation across life sciences and diagnostics.
Read MorePosted by Chris Wolski | May 9, 2023 | Covid 19, Molecular Diagnostics, POC Rapid Assays |
The expiration of the federal Public Health Emergency for COVID-19 provides new impetus for lab innovation in the post-pandemic world.
Read MorePosted by Melanie Hamilton-Basich | May 4, 2023 | Point-of-Care |
New findings suggest offering genetic testing at the point of care along with a digital cancer risk assessment could increase uptake.
Read More